Select Page

The latest report on Human Papillomavirus Testing Market (by product (consumables and systems), end-user (hospitals, physicians’ office laboratories and clinical diagnostic laboratories)) provides complete and deep insights into the market dynamics and growth of human papillomavirus testing industry. Latest information on market risks, industry chain structure human papillomavirus testing cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential human papillomavirus testing growth factors.According to report the global human papillomavirus testing market is projected to grow at a CAGR of 15.2% over the forecast period of 2018-2024.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

A viral infection that is passed between people through skin-to-skin contact is known as Human papillomavirus (HPV). According to the Centers for Disease Control and Prevention (CDC), HPV is the most common sexually transmitted infection that affects both men and women. Cervix cell changes is caused by human papillomavirus. The HPV test checks for the virus, not cell changes.

Growing Prevalence of Cervical Cancer and Early Detection to Prevent this Infection is Likely to Drive the Growth of this Market

The growing prevalence of cervical cancer and early detection to prevent this infection is likely to drive the growth of this market in the coming years. Additionally, rising incidences of vaginal cancer, increased adoption of screening tests, the increasing number of awareness programs by government and private organizations, and technologically advancement are some of the factors that are likely to boost the growth of the market.

Get this Section as a Free Customization in the Report along with 30% Discount on the Study:

“We have Decided to Extend our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Global on Human Papillomavirus Testing Market Amidst COVID-19.”

North America is Expected to Be Largest Market for HPV Testing

Among the geographies, North America is expected to be largest market for HPV testing followed by Europe due to government initiatives in various countries such as the US, Canada, in this region. While, Asia-Pacific is expected to grow fast during the forecast period, owing to the increasing awareness about this infection, and growing government support in countries like China and India is likely to augment the growth in this region.

The rising competition among test kit manufacturing companies will increase the competitive environment in the market. For instance, Becton Dickinson and Company (BD) received the FDA clearance for the fully automated cervical cancer screening system, in 2016. This automated system reduces human interference as well as the cost and, thus increasing overall workflow efficiency.

Segmentation of the Human Papillomavirus Testing Industry

The report on global human papillomavirus testing market covers segments such as, product and end-user. On the basis of product the global human papillomavirus testing market is categorized into consumables and systems. On the basis ofend-user, the global human papillomavirus testing market is categorized into hospitals, physicians’ office laboratories and clinical diagnostic laboratories.

Key Players in the Human Papillomavirus Testing Industry

The report provides profiles of the companies in the global human papillomavirus testing market such as, Cepheid, Abbott Laboratories, Arbor Vita, Roche Diagnostics, Genera Biosystems, Breakspear Medical, IncellDx, Delphi Bioscience, Fujirebio Diagnostics and OralDNA Labs.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the human papillomavirus testing.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research– Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.